Thomas D. Salus - 02 Mar 2026 Form 4 Insider Report for LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)

Role
Chief Legal & Administration
Signature
/s/ Aaron S. Perlitsh, Attorney-In-Fact for Thomas D Salus
Issuer symbol
LFCR
Transactions as of
02 Mar 2026
Net transactions value
$0
Form type
4
Filing time
02 Mar 2026, 18:52:42 UTC
Previous filing
10 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Salus Thomas D. Chief Legal & Administration C/O LIFECORE BIOMEDICAL, INC., 3515 LYMAN BLVD., CHASKA /s/ Aaron S. Perlitsh, Attorney-In-Fact for Thomas D Salus 02 Mar 2026 0002062209

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LFCR Common Stock Award +30,000 +12% 270,978 02 Mar 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis.
F2 Restricted Stock Units will vest on the 3rd anniversary of the grant date.